1. Home
  2. GNLX vs GROY Comparison

GNLX vs GROY Comparison

Compare GNLX & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
    SELLHOLDBUYas of a day ago
  • GROY
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • GNLX 2001
  • GROY 2020
  • Country
  • GNLX United States
  • GROY Canada
  • Employees
  • GNLX N/A
  • GROY N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • GROY
  • Sector
  • GNLX Health Care
  • GROY
  • Exchange
  • GNLX Nasdaq
  • GROY Nasdaq
  • Market Cap
  • GNLX 184.4M
  • GROY 206.6M
  • IPO Year
  • GNLX 2023
  • GROY 2021
  • Fundamental
  • Price
  • GNLX $2.56
  • GROY $1.44
  • Analyst Decision
  • GNLX Strong Buy
  • GROY Strong Buy
  • Analyst Count
  • GNLX 4
  • GROY 4
  • Target Price
  • GNLX $18.25
  • GROY $3.31
  • AVG Volume (30 Days)
  • GNLX 167.0K
  • GROY 1.4M
  • Earning Date
  • GNLX 03-28-2025
  • GROY 03-20-2025
  • Dividend Yield
  • GNLX N/A
  • GROY N/A
  • EPS Growth
  • GNLX N/A
  • GROY N/A
  • EPS
  • GNLX N/A
  • GROY N/A
  • Revenue
  • GNLX $8,000.00
  • GROY $10,103,000.00
  • Revenue This Year
  • GNLX N/A
  • GROY $145.05
  • Revenue Next Year
  • GNLX N/A
  • GROY $48.73
  • P/E Ratio
  • GNLX N/A
  • GROY N/A
  • Revenue Growth
  • GNLX N/A
  • GROY 231.46
  • 52 Week Low
  • GNLX $1.60
  • GROY $1.16
  • 52 Week High
  • GNLX $6.50
  • GROY $2.21
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 32.11
  • GROY 50.11
  • Support Level
  • GNLX $3.03
  • GROY $1.39
  • Resistance Level
  • GNLX $3.35
  • GROY $1.51
  • Average True Range (ATR)
  • GNLX 0.36
  • GROY 0.07
  • MACD
  • GNLX -0.11
  • GROY -0.01
  • Stochastic Oscillator
  • GNLX 0.00
  • GROY 45.31

Stock Price Comparison Chart: GNLX vs GROY

GNLX
GROY
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250510152025303540GNLX VS GROY

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

About GROY Gold Royalty Corp.

Gold Royalty Corp is a precious metals-focused royalty and streaming company. It offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use